NO20012097L - Fremgangsmåter og sammensetninger for forebygging av toleranse for medisineringer - Google Patents

Fremgangsmåter og sammensetninger for forebygging av toleranse for medisineringer

Info

Publication number: NO20012097L
Authority: NO; Norway
Prior art keywords: medications; compositions; methods; preventing tolerance; tolerance
Prior art date: 1998-10-30

Application number

NO20012097A

Other languages

English (en)

Other versions

NO333194B1 (no

NO20012097D0 (no

Inventor

Tahir Ahmed

Original Assignee

Baker Norton Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-30

Filing date

2001-04-27

Publication date

2001-06-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26803748&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20012097(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-04-27 Application filed by Baker Norton Pharma filed Critical Baker Norton Pharma

2001-04-27 Publication of NO20012097D0 publication Critical patent/NO20012097D0/no

2001-06-15 Publication of NO20012097L publication Critical patent/NO20012097L/no

2013-04-02 Publication of NO333194B1 publication Critical patent/NO333194B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Emergency Medicine (AREA)
General Chemical & Material Sciences (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Investigating Or Analysing Biological Materials (AREA)

NO20012097A 1998-10-30 2001-04-27 Sammensetninger og anvendelse av disse for forebygging av toleranse for medisinering NO333194B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US10650798P	1998-10-30	1998-10-30
US09/362,540 US6235725B1 (en)	1998-10-30	1999-07-28	Methods and compositions for the prevention of tolerance to medications
PCT/US1999/024034 WO2000025723A2 (en)	1998-10-30	1999-10-13	Methods and compositions for the prevention of tolerance to medications

Publications (3)

Publication Number	Publication Date
NO20012097D0 NO20012097D0 (no)	2001-04-27
NO20012097L true NO20012097L (no)	2001-06-15
NO333194B1 NO333194B1 (no)	2013-04-02

Family

ID=26803748

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20012097A NO333194B1 (no)	1998-10-30	2001-04-27	Sammensetninger og anvendelse av disse for forebygging av toleranse for medisinering

Country Status (25)

Country	Link
US (1)	US6235725B1 (no)
EP (1)	EP1124563B1 (no)
JP (1)	JP4585121B2 (no)
CN (2)	CN100352448C (no)
AR (2)	AR023911A1 (no)
AT (1)	ATE277621T1 (no)
AU (1)	AU760119B2 (no)
BR (1)	BR9915818A (no)
CA (1)	CA2348926C (no)
CO (1)	CO5160320A1 (no)
CY (1)	CY1107493T1 (no)
CZ (1)	CZ297914B6 (no)
DE (1)	DE69920734T2 (no)
ES (1)	ES2228173T3 (no)
HK (1)	HK1041596A1 (no)
HU (1)	HUP0302492A3 (no)
IL (2)	IL142865A0 (no)
IS (1)	IS2321B (no)
NO (1)	NO333194B1 (no)
NZ (1)	NZ511399A (no)
PL (1)	PL195592B1 (no)
PT (1)	PT1124563E (no)
SK (1)	SK285150B6 (no)
TW (1)	TW565451B (no)
WO (1)	WO2000025723A2 (no)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9902689D0 (en) *	1999-02-08	1999-03-31	Novartis Ag	Organic compounds
US9006175B2 (en)	1999-06-29	2015-04-14	Mannkind Corporation	Potentiation of glucose elimination
BR0107304A (pt) *	2000-10-12	2002-08-13	Boehringer Ingelheim Pharma	Pó para inalação contendo tiotrópio
US6667344B2 (en) *	2001-04-17	2003-12-23	Dey, L.P.	Bronchodilating compositions and methods
US20030055026A1 (en) *	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
US20030070679A1 (en) *	2001-06-01	2003-04-17	Boehringer Ingelheim Pharma Kg	Capsules containing inhalable tiotropium
US6702997B2 (en)	2001-10-26	2004-03-09	Dey, L.P.	Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US20030140920A1 (en) *	2001-10-26	2003-07-31	Dey L.P.	Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
US20030191151A1 (en) *	2001-10-26	2003-10-09	Imtiaz Chaudry	Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US20030203930A1 (en) *	2001-10-26	2003-10-30	Imtiaz Chaudry	Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
JP2003221335A (ja)	2001-10-26	2003-08-05	Dey Lp	慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
ES2527096T3 (es) *	2002-02-18	2015-01-20	Ockham Biotech Limited	Combinación de ADNasa I y glucosaminoglucanos para su uso en limpieza de ADN extracelular
AU2003205898A1 (en) *	2002-02-18	2003-09-04	University Of Southampton	Combination therapy for respiratory disorders
DE60323973D1 (de) *	2002-02-18	2008-11-20	Univ Southampton	Verwendung von glykosaminglykanen wie z.b. heparin zur behandlung von atemerkrankungen wie copd
AU2003220125B2 (en)	2002-03-20	2006-06-15	Mannkind Corporation	Inhalation apparatus
JP2006501815A (ja) *	2002-04-25	2006-01-19	モメンタファーマシューティカルズインコーポレイテッド	粘膜送達のための方法および製品
US20040023935A1 (en) *	2002-08-02	2004-02-05	Dey, L.P.	Inhalation compositions, methods of use thereof, and process for preparation of same
EP2319585A1 (en) *	2002-08-29	2011-05-11	Cipla Ltd.	Pharmaceutical products and compositions comprising salmeterol, fluticasone and ipratropium or tiotropium
US7763280B2 (en) *	2002-11-28	2010-07-27	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Tiotropium containing powder formulation for inhalation
US20040109826A1 (en) *	2002-12-06	2004-06-10	Dey, L.P.	Stabilized albuterol compositions and method of preparation thereof
WO2004100966A1 (ja)	2003-05-16	2004-11-25	Bbk Bio Corporation	病態起因物質の生体への接触防止用製剤
TWI359675B (en) *	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
US20050043343A1 (en) *	2003-07-28	2005-02-24	Boehringer Ingelheim International Gmbh	Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor
PL1786784T3 (pl)	2004-08-20	2011-04-29	Mannkind Corp	Kataliza syntezy diketopiperazyn
EP2314298B1 (en)	2004-08-23	2015-05-27	MannKind Corporation	Microparticles comprising diketopiperazine salts for drug delivery
AU2006290870B2 (en)	2005-09-14	2013-02-28	Mannkind Corporation	Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
DK1986679T3 (da)	2006-02-22	2017-11-20	Mannkind Corp	Fremgangsmåde til forbedring af mikropartiklers farmaceutiske egenskaber omfattende diketopiperazin og et aktivt indholdsstof
US8485180B2 (en)	2008-06-13	2013-07-16	Mannkind Corporation	Dry powder drug delivery system
CN103252007B (zh)	2008-06-13	2016-06-22	曼金德公司	干粉吸入器和用于药物输送的系统
JP5479465B2 (ja)	2008-06-20	2014-04-23	マンカインドコーポレイション	吸入努力をリアルタイムにプロファイルする対話式機器および方法
TWI614024B (zh)	2008-08-11	2018-02-11	曼凱公司	超快起作用胰島素之用途
US8314106B2 (en)	2008-12-29	2012-11-20	Mannkind Corporation	Substituted diketopiperazine analogs for use as drug delivery agents
EP2676695A3 (en)	2009-03-11	2017-03-01	MannKind Corporation	Apparatus, system and method for measuring resistance of an inhaler
KR101875969B1 (ko)	2009-06-12	2018-07-06	맨카인드 코포레이션	한정된 비표면적을 갖는 디케토피페라진 마이크로입자
WO2011056889A1 (en)	2009-11-03	2011-05-12	Mannkind Corporation	An apparatus and method for simulating inhalation efforts
WO2011133687A2 (en) *	2010-04-20	2011-10-27	President And Fellows Of Harvard College	Methods and compositions for inhibition of beta2-adrenergic receptor degradation
RU2531455C2 (ru)	2010-06-21	2014-10-20	Маннкайнд Корпорейшн	Системы и способы доставки сухих порошковых лекарств
CN105667994B (zh)	2011-04-01	2018-04-06	曼金德公司	用于药物药盒的泡罩包装
WO2012174472A1 (en)	2011-06-17	2012-12-20	Mannkind Corporation	High capacity diketopiperazine microparticles
WO2013063160A1 (en)	2011-10-24	2013-05-02	Mannkind Corporation	Methods and compositions for treating pain
SG11201500218VA (en)	2012-07-12	2015-03-30	Mannkind Corp	Dry powder drug delivery systems and methods
EP2911690A1 (en)	2012-10-26	2015-09-02	MannKind Corporation	Inhalable influenza vaccine compositions and methods
EP2970149B1 (en)	2013-03-15	2019-08-21	MannKind Corporation	Microcrystalline diketopiperazine compositions and methods
CN105451716A (zh)	2013-07-18	2016-03-30	曼金德公司	热稳定性干粉药物组合物和方法
WO2015021064A1 (en)	2013-08-05	2015-02-12	Mannkind Corporation	Insufflation apparatus and methods
US10307464B2 (en)	2014-03-28	2019-06-04	Mannkind Corporation	Use of ultrarapid acting insulin
CN104069497A (zh) *	2014-06-27	2014-10-01	东莞市凯法生物医药有限公司	一种降低药物耐受性的组合物、方法及其应用
US10561806B2 (en)	2014-10-02	2020-02-18	Mannkind Corporation	Mouthpiece cover for an inhaler
US20190070244A1 (en) *	2017-06-30	2019-03-07	The New Zealand Institute For Plant And Food Research Limited	Boysenberry compositions and methods of preparation and use thereof
CA3070571A1 (en)	2017-08-08	2019-02-14	Odette M. Shaw	Boysenberry, apple, and blackcurrant compositions and methods of preparation and use therefor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1195497B (it)	1983-03-08	1988-10-19	Opocrin Spa	Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina
US4906476A (en)	1988-12-14	1990-03-06	Liposome Technology, Inc.	Novel liposome composition for sustained release of steroidal drugs in lungs
US5032679A (en)	1988-12-15	1991-07-16	Glycomed, Inc.	Heparin fragments as inhibitors of smooth muscle cell proliferation
US5380716A (en)	1988-12-15	1995-01-10	Glycomed, Inc.	Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation
US5192548A (en)	1990-04-30	1993-03-09	Riker Laboratoires, Inc.	Device
SE9302777D0 (sv)	1993-08-27	1993-08-27	Astra Ab	Process for conditioning substances
US5874063A (en)	1991-04-11	1999-02-23	Astra Aktiebolag	Pharmaceutical formulation
US5714376A (en)	1991-10-23	1998-02-03	Massachusetts Institute Of Technology	Heparinase gene from flavobacterium heparinum
US5736124A (en)	1991-12-12	1998-04-07	Glaxo Group Limited	Aerosol formulations containing P134a and particulate medicament
ES2079210T3 (es)	1991-12-12	1996-01-01	Glaxo Group Ltd	Formulacion farmaceutica de aerosol.
WO1993011773A1 (en) *	1991-12-18	1993-06-24	Aktiebolaget Astra	New combination of formoterol and budesonide
US5690910A (en) *	1995-08-18	1997-11-25	Baker Norton Pharmaceuticals, Inc.	Method for treating asthma

1999
- 1999-07-28 US US09/362,540 patent/US6235725B1/en not_active Expired - Lifetime
- 1999-10-13 WO PCT/US1999/024034 patent/WO2000025723A2/en not_active Ceased
- 1999-10-13 BR BR9915818-3A patent/BR9915818A/pt not_active Application Discontinuation
- 1999-10-13 PT PT99971300T patent/PT1124563E/pt unknown
- 1999-10-13 EP EP99971300A patent/EP1124563B1/en not_active Expired - Lifetime
- 1999-10-13 CA CA2348926A patent/CA2348926C/en not_active Expired - Fee Related
- 1999-10-13 CN CNB2004100629128A patent/CN100352448C/zh not_active Expired - Fee Related
- 1999-10-13 DE DE69920734T patent/DE69920734T2/de not_active Expired - Lifetime
- 1999-10-13 AU AU12051/00A patent/AU760119B2/en not_active Ceased
- 1999-10-13 HK HK02103273.0A patent/HK1041596A1/zh unknown
- 1999-10-13 CZ CZ20011518A patent/CZ297914B6/cs not_active IP Right Cessation
- 1999-10-13 CN CN99813923A patent/CN1329496A/zh active Pending
- 1999-10-13 SK SK590-2001A patent/SK285150B6/sk not_active IP Right Cessation
- 1999-10-13 PL PL99364727A patent/PL195592B1/pl unknown
- 1999-10-13 IL IL14286599A patent/IL142865A0/xx active IP Right Grant
- 1999-10-13 HU HU0302492A patent/HUP0302492A3/hu not_active Application Discontinuation
- 1999-10-13 NZ NZ511399A patent/NZ511399A/en not_active IP Right Cessation
- 1999-10-13 JP JP2000579168A patent/JP4585121B2/ja not_active Expired - Fee Related
- 1999-10-13 AT AT99971300T patent/ATE277621T1/de active
- 1999-10-13 ES ES99971300T patent/ES2228173T3/es not_active Expired - Lifetime
- 1999-10-28 AR ARP990105443A patent/AR023911A1/es not_active Application Discontinuation
- 1999-10-29 CO CO99068642A patent/CO5160320A1/es unknown
- 1999-11-09 TW TW088118719A patent/TW565451B/zh not_active IP Right Cessation
2001
- 2001-04-27 IS IS5928A patent/IS2321B/is unknown
- 2001-04-27 NO NO20012097A patent/NO333194B1/no not_active IP Right Cessation
- 2001-04-30 IL IL142865A patent/IL142865A/en not_active IP Right Cessation
2004
- 2004-12-06 CY CY20041101437T patent/CY1107493T1/el unknown
2011
- 2011-09-07 AR ARP110103258A patent/AR082913A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU1205100A (en)	2000-05-22
IS5928A (is)	2001-04-27
SK285150B6 (sk)	2006-07-07
AR023911A1 (es)	2002-09-04
CA2348926A1 (en)	2000-05-11
PL364727A1 (en)	2004-12-13
IS2321B (is)	2007-12-15
NO333194B1 (no)	2013-04-02
CZ20011518A3 (cs)	2002-04-17
CO5160320A1 (es)	2002-05-30
NZ511399A (en)	2004-09-24
CY1107493T1 (el)	2013-03-13
SK5902001A3 (en)	2002-07-02
PT1124563E (pt)	2005-01-31
IL142865A0 (en)	2002-03-10
EP1124563B1 (en)	2004-09-29
HUP0302492A2 (hu)	2003-11-28
JP2002535245A (ja)	2002-10-22
PL195592B1 (pl)	2007-10-31
CZ297914B6 (cs)	2007-04-25
CN100352448C (zh)	2007-12-05
EP1124563A2 (en)	2001-08-22
BR9915818A (pt)	2002-06-18
JP4585121B2 (ja)	2010-11-24
HUP0302492A3 (en)	2005-05-30
CA2348926C (en)	2011-08-23
AU760119B2 (en)	2003-05-08
IL142865A (en)	2006-07-05
CN1572303A (zh)	2005-02-02
AR082913A2 (es)	2013-01-16
EP1124563A4 (en)	2002-01-02
DE69920734T2 (de)	2005-10-06
NO20012097D0 (no)	2001-04-27
DE69920734D1 (de)	2004-11-04
TW565451B (en)	2003-12-11
CN1329496A (zh)	2002-01-02
HK1041596A1 (zh)	2002-07-12
US6235725B1 (en)	2001-05-22
WO2000025723A3 (en)	2000-07-27
ATE277621T1 (de)	2004-10-15
ES2228173T3 (es)	2005-04-01
WO2000025723A2 (en)	2000-05-11

Publication	Publication Date	Title
NO20012097D0 (no)	2001-04-27	Fremgangsmåter og sammensetninger for forebygging av toleranse overfor medisineringer
NO20016277L (no)	2002-02-28	Systemer og fremgangsmåter for aerolisering av farmasöytiske sammensetninger
EA199900373A3 (ru)	2000-08-28	Фармацевтические композиции
ID27415A (id)	2001-04-05	Komposisi farmaseutik
NO20005913D0 (no)	2000-11-22	Legemiddelsammensetning
NO20003096D0 (no)	2000-06-15	Sammensetninger og fremgangsmÕter for behandling av ADD
FI20071025L (fi)	2007-12-28	Farmaseuttisia koostumuksia
ID29262A (id)	2001-08-16	Komposisi farmasi
LV12624B (lv)	2001-09-20	Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana
PT1139761E (pt)	2003-10-31	Composicoes herbicidas e concentrados tensioactivos
ID17774A (id)	1998-01-29	Komposisi farmasi antitrombosis
ID27201A (id)	2001-03-08	Komposisi farmasi
IS2841B (is)	2013-08-15	Samstæða hluta og lyfjasamsetningar
PT969815E (pt)	2005-07-29	Composicoes farmaceuticas
DK1066261T3 (da)	2006-01-30	Pyridinderivat og farmaceutisk præparat indeholdende samme
NO20005763D0 (no)	2000-11-14	DHEA-sammensetning og metode
PT941100E (pt)	2003-10-31	Composicoes farmaceuticas
DE69901370D1 (de)	2002-06-06	Teilchenförmige Zusammensetzungen
EE200000330A (et)	2001-08-15	Farmatseutilised kompositsioonid
ITMI942166A0 (it)	1994-10-21	Composizioni farmaceutiche miorilassanti
EE04217B1 (et)	2004-02-16	Farmatseutilised kompositsioonid
FI962738A7 (fi)	1996-07-03	Farmaseuttiset koostumukset
FI954050A7 (fi)	1996-03-02	Lääkekoostumuksia
NO994436L (no)	1999-09-13	Farmasöytiske sammensetninger
DK1133300T3 (da)	2005-05-09	Desmethylolanzapinsammensætninger og fremgangsmåder

Legal Events

Date	Code	Title	Description
2013-10-21	CHAD	Change of the owner's name or address (par. 44 patent law, par. patentforskriften)	Owner name: TAHIR AHMED, US
2018-05-28	MM1K	Lapsed by not paying the annual fees